Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Franchini

Showing results (271-280 of 297) with videos related to

Pageof 30
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 9, 2007
Inhibition of UCP2 expression reverses diet-induced diabetes mellitus by effects on both insulin secretion and actionCláudio T De Souza, Eliana P Araújo, Luiz F Stoppiglia, et al.
British Journal of Anaesthesia|January 10, 1998
Autotransfusion in major orthopaedic surgery: experience with 1785 patientsB Borghi, E Pignotti, M Montebugnoli, et al.
Journal of Molecular and Cellular Cardiology|November 8, 2011
Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathwaysC F M Z Clemente, J Xavier-Neto, A P Dalla Costa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 12, 2001
Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimenZ Hel, W P Tsai, A Thornton, et al.
Diabetes|February 12, 2017
Expression of Concern. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet-Fed Mice. Diabetes 2009;58:2910-2919. DOI: 10.2337/db08-0506. PMID: 19696185Patricia O Prada, Eduardo R Ropelle, Rosa H Mourão, et al.
Diabetes|April 29, 2017
Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet-Fed Mice. Diabetes 2009;58:2910-2919. DOI: 10.2337/db08-0506. PMID: 19696185Patricia O Prada, Eduardo R Ropelle, Rosa H Mourão, et al.
Nature Medicine|December 1, 2001
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaquesI M Belyakov, Z Hel, B Kelsall, et al.
Diabetes|August 22, 2009
EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed micePatricia O Prada, Eduardo R Ropelle, Rosa H Mourão, et al.
Journal of Internal Medicine|May 22, 2022
Randomized clinical trial of BCG vaccine in patients with convalescent COVID-19: Clinical evolution, adverse events, and humoral immune responseMehrsa Jalalizadeh, Keini Buosi, Franciele A V Dionato, et al.
Biomed Research International|February 19, 2019
Planning, Implementing, and Running a Multicentre Preterm Birth Study with Biobank Resources in Brazil: The Preterm SAMBA StudyRenato T Souza, Jose G Cecatti, Maria L Costa, et al.
Pageof 30

Showing results (271-280 of 297) with videos related to

Sort By:
Pageof 30
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 9, 2007
Inhibition of UCP2 expression reverses diet-induced diabetes mellitus by effects on both insulin secretion and actionCláudio T De Souza, Eliana P Araújo, Luiz F Stoppiglia, et al.
British Journal of Anaesthesia|January 10, 1998
Autotransfusion in major orthopaedic surgery: experience with 1785 patientsB Borghi, E Pignotti, M Montebugnoli, et al.
Journal of Molecular and Cellular Cardiology|November 8, 2011
Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathwaysC F M Z Clemente, J Xavier-Neto, A P Dalla Costa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 12, 2001
Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimenZ Hel, W P Tsai, A Thornton, et al.
Diabetes|February 12, 2017
Expression of Concern. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet-Fed Mice. Diabetes 2009;58:2910-2919. DOI: 10.2337/db08-0506. PMID: 19696185Patricia O Prada, Eduardo R Ropelle, Rosa H Mourão, et al.
Diabetes|April 29, 2017
Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet-Fed Mice. Diabetes 2009;58:2910-2919. DOI: 10.2337/db08-0506. PMID: 19696185Patricia O Prada, Eduardo R Ropelle, Rosa H Mourão, et al.
Nature Medicine|December 1, 2001
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaquesI M Belyakov, Z Hel, B Kelsall, et al.
Diabetes|August 22, 2009
EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed micePatricia O Prada, Eduardo R Ropelle, Rosa H Mourão, et al.
Journal of Internal Medicine|May 22, 2022
Randomized clinical trial of BCG vaccine in patients with convalescent COVID-19: Clinical evolution, adverse events, and humoral immune responseMehrsa Jalalizadeh, Keini Buosi, Franciele A V Dionato, et al.
Biomed Research International|February 19, 2019
Planning, Implementing, and Running a Multicentre Preterm Birth Study with Biobank Resources in Brazil: The Preterm SAMBA StudyRenato T Souza, Jose G Cecatti, Maria L Costa, et al.
Pageof 30